- HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or NefDaniel Sauter
Institute of Molecular Virology, Ulm University Medical Center, 89069, Ulm, Germany
Retrovirology 8:103. 2011..Here, we examined how long Group P may have been circulating in humans and determined its capability to antagonize human tetherin as an indicator of adaptation to humans...
- Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta
Division of Infection and Immunity, University College London Medical School, London, United Kingdom
Pediatr Infect Dis J 29:e57-62. 2010..There are few medium-term virologic data in children from resource-limited settings taking adult fixed-dose-combination antiretroviral therapy (cART) without viral load monitoring...
- The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domainsJean L Mbisa
Virus Reference Department, Microbiology Services, Colindale, Health Protection Agency, London, UK
Retrovirology 8:31. 2011..In this study we examined the genotypic, phenotypic and fitness correlates associated with the development of Q151M MDR in the absence of viral load monitoring...